Expression of Hepatic Stellate Cell Activation-related Genes in HBV-, HCV-, and Nonalcoholic Fatty Liver Disease-associated Fibrosis

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2020 May 23

PMID 32442221

Citations 11

Authors

Lu He

Hui Yuan

Junjie Liang

Jian Hong

Chen Qu

Affiliations

Soon will be listed here.

Abstract

Liver fibrosis is a manifestation of chronic liver injury. It leads to hepatic dysfunction and is a critical element in the pathogenesis of cirrhosis and hepatocellular carcinoma. The activation of hepatic stellate cells (HSC) plays a central role in liver fibrogenesis of different etiologies. To elucidate the molecular mechanism of this phenomenon, it is important to analyze the changes in gene expression that accompany the HSC activation process. In this study, we isolated quiescent and activated HSCs from control mice and mice with CCl4-induced liver fibrosis, respectively, and performed RNA sequencing to compare the differences in gene expression patterns between the two types of HSCs. We also reanalyzed public gene expression data for fibrotic liver tissues isolated from patients with HBV infection, HCV infection, and nonalcoholic fatty liver disease to investigate the gene expression changes during liver fibrosis of these three etiologies. We detected 146 upregulated and 18 downregulated genes in activated HSCs, which were implicated in liver fibrosis as well. Among the overlapping genes, seven transcription factor-encoding genes, ARID5B, GATA6, MITF, PBX1, PLAGL1, SOX4, and SOX9, were upregulated, while one, RXRA, was downregulated. These genes were suggested to play a critical role in HSC activation, and subsequently, in the promotion of liver fibrosis. We undertook the RNA sequencing of quiescent and activated HSCs and analyzed the expression profiles of genes associated with HSC activation in liver fibrotic tissues from different liver diseases, and also aimed to elucidate the changes in gene expression patterns associated with HSC activation and liver fibrosis.

Citing Articles

The Malignant Transformation of Viral Hepatitis to Hepatocellular Carcinoma: Mechanisms and Interventions.

Yuan H, Xu R, Li S, Zheng M, Tong Q, Xiang M MedComm (2020). 2025; 6(3):e70121.

PMID: 40060195 PMC: 11890166. DOI: 10.1002/mco2.70121.

SOX9: a key transcriptional regulator in organ fibrosis.

Li Y, Xing Y, Liu N, Liu B, Wang Z Front Pharmacol. 2025; 16:1507282.

PMID: 39974732 PMC: 11835943. DOI: 10.3389/fphar.2025.1507282.

Association between neutrophil-to-high-density lipoprotein cholesterol ratio and metabolic dysfunction-associated steatotic liver disease and liver fibrosis in the US population: a nationally representative cross-sectional study using NHANES data....

Lu Y, Xu X, Wu J, Ji L, Huang H, Chen M BMC Gastroenterol. 2024; 24(1):300.

PMID: 39237899 PMC: 11378436. DOI: 10.1186/s12876-024-03394-6.

Transcriptomic screening of novel targets of sericin in human hepatocellular carcinoma cells.

Jantaravinid J, Tirawanchai N, Ampawong S, Kengkoom K, Somkasetrin A, Nakhonsri V Sci Rep. 2024; 14(1):5455.

PMID: 38443583 PMC: 10914811. DOI: 10.1038/s41598-024-56179-y.

Formation and Investigation of Cell-Derived Nanovesicles as Potential Therapeutics against Chronic Liver Disease.

Ganguin A, Skorup I, Streb S, Othman A, Luciani P Adv Healthc Mater. 2023; 12(30):e2300811.

PMID: 37669775 PMC: 11468924. DOI: 10.1002/adhm.202300811.

References

Sasaki R, Kanda T, Nakamura M, Nakamoto S, Haga Y, Wu S . Possible Involvement of Hepatitis B Virus Infection of Hepatocytes in the Attenuation of Apoptosis in Hepatic Stellate Cells. PLoS One. 2016; 11(1):e0146314. PMC: 4701422. DOI: 10.1371/journal.pone.0146314. View

Stefanovic B, Manojlovic Z, Vied C, Badger C, Stefanovic L . Discovery and evaluation of inhibitor of LARP6 as specific antifibrotic compound. Sci Rep. 2019; 9(1):326. PMC: 6344531. DOI: 10.1038/s41598-018-36841-y. View

Wang M, Gong Q, Zhang J, Chen L, Zhang Z, Lu L . Characterization of gene expression profiles in HBV-related liver fibrosis patients and identification of ITGBL1 as a key regulator of fibrogenesis. Sci Rep. 2017; 7:43446. PMC: 5337978. DOI: 10.1038/srep43446. View

Starkel P, Leclercq I . Animal models for the study of hepatic fibrosis. Best Pract Res Clin Gastroenterol. 2011; 25(2):319-33. DOI: 10.1016/j.bpg.2011.02.004. View

Friedman S . Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev. 2008; 88(1):125-72. PMC: 2888531. DOI: 10.1152/physrev.00013.2007. View

Mas V, Maluf D, Archer K, Yanek K, Kong X, Kulik L . Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma. Mol Med. 2008; 15(3-4):85-94. PMC: 2605622. DOI: 10.2119/molmed.2008.00110. View

Higashi T, Friedman S, Hoshida Y . Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev. 2017; 121:27-42. PMC: 5682243. DOI: 10.1016/j.addr.2017.05.007. View

Ye H, Zhang J, Chen X, Wu P, Chen L, Zhang G . Ursodeoxycholic acid alleviates experimental liver fibrosis involving inhibition of autophagy. Life Sci. 2019; 242:117175. DOI: 10.1016/j.lfs.2019.117175. View

Mederacke I, Dapito D, Affo S, Uchinami H, Schwabe R . High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers. Nat Protoc. 2015; 10(2):305-15. PMC: 4681437. DOI: 10.1038/nprot.2015.017. View

10.

Aydin M, Akcali K . Liver fibrosis. Turk J Gastroenterol. 2018; 29(1):14-21. PMC: 6322608. DOI: 10.5152/tjg.2018.17330. View

11.

Huang C, Sun C, Zhao F, Zhang Y, Li D . miR-33a levels in hepatic and serum after chronic HBV-induced fibrosis. J Gastroenterol. 2014; 50(4):480-90. DOI: 10.1007/s00535-014-0986-3. View

12.

Lambert S, Jolma A, Campitelli L, Das P, Yin Y, Albu M . The Human Transcription Factors. Cell. 2018; 172(4):650-665. DOI: 10.1016/j.cell.2018.01.029. View

13.

Pedroza M, To S, Smith J, Agarwal S . Cadherin-11 contributes to liver fibrosis induced by carbon tetrachloride. PLoS One. 2019; 14(7):e0218971. PMC: 6608953. DOI: 10.1371/journal.pone.0218971. View

14.

Schuppan D, Afdhal N . Liver cirrhosis. Lancet. 2008; 371(9615):838-51. PMC: 2271178. DOI: 10.1016/S0140-6736(08)60383-9. View

15.

Li J, Wang Y, Ma M, Jiang S, Zhang X, Zhang Y . Autocrine CTHRC1 activates hepatic stellate cells and promotes liver fibrosis by activating TGF-β signaling. EBioMedicine. 2019; 40:43-55. PMC: 6412555. DOI: 10.1016/j.ebiom.2019.01.009. View

16.

Trapnell C, Williams B, Pertea G, Mortazavi A, Kwan G, van Baren M . Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol. 2010; 28(5):511-5. PMC: 3146043. DOI: 10.1038/nbt.1621. View

17.

Yu G, Wang L, Han Y, He Q . clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012; 16(5):284-7. PMC: 3339379. DOI: 10.1089/omi.2011.0118. View

18.

Gautier L, Cope L, Bolstad B, Irizarry R . affy--analysis of Affymetrix GeneChip data at the probe level. Bioinformatics. 2004; 20(3):307-15. DOI: 10.1093/bioinformatics/btg405. View

19.

Liu X, Xu J, Rosenthal S, Zhang L, McCubbin R, Meshgin N . Identification of Lineage-Specific Transcription Factors That Prevent Activation of Hepatic Stellate Cells and Promote Fibrosis Resolution. Gastroenterology. 2020; 158(6):1728-1744.e14. PMC: 7252905. DOI: 10.1053/j.gastro.2020.01.027. View

20.

Crespo Yanguas S, Cogliati B, Willebrords J, Maes M, Colle I, Van den Bossche B . Experimental models of liver fibrosis. Arch Toxicol. 2015; 90(5):1025-1048. PMC: 4705434. DOI: 10.1007/s00204-015-1543-4. View